Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Master's Award: Canada Graduate Scholarships

University of Toronto

$17,500.00

Understanding the Genotype-Phenotype Profile in Pediatric Hypertrophic Cardiomyopathy using the Myocardial Stiffness Assessment by Ultrafast Ultrasound Imaging

FY 2022-23

Summary
Hypertrophic cardiomyopathy (HCM) is a genetic disease in which heart muscle stiffens and become abnormally thick, making it difficult for the heart to pump blood. This disease is a common cause of poor health & even death in children & young adults. We are currently limited to visual inspection done by physicians on ultrasound images of the heart to identify and assess the progression of the disease as there is no other non-invasive technique clinically available to do so. Several known genetic mutations can provide insight about the likelihood of disease in an individual, however the link between mutation & the progression of disease and outcomes is not well known. Lacking a clinical tool to characterize HCM also limits our ability to study the differences in males and females suffering from HCM due to social, hormonal, & genetic reasons. Previous studies have used predominately male populations which may not be suitable for implementing in females. Therefore, we need to improve our ability to identify HCM patients at greater risk. Using a newly developed technology called ultrasound ultrafast imaging, we are now able to non-invasively estimate heart stiffness in HCM patients. The technique has already been used to estimate heart stiffness in healthy & HCM adults. The objective of this research project is to understand the link between heart stiffness, genetic mutation, and clinical events in pediatric and young adult HCM. Having equal number of male & female HCM patients in study will allow us to observe sex-related differences in heart stiffness in HCM patients. In this research study we will recruit infants, youths & young adults with HCM in four hospitals across Ontario. This research project promises to redefine how we diagnose, and access risks in HCM patients.
Program
Master's Award: Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
485914
Name
Malik Aimen
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Prcname2
Special Cases - Awards Programs
Projecttitle
Understanding the Genotype-Phenotype Profile in Pediatric Hypertrophic Cardiomyopathy using the Myocardial Stiffness Assessment by Ultrafast Ultrasound Imaging
Programtype2
Studentship Programs
Orgnameinp2
University of Toronto
Cihramount2
$17,500
Cihrequipment2
$0
Programname2
Master's Award: Canada Graduate Scholarships
Keyworddelim
Diastolic Function; Genetic Mutation; Hypertrophic Cardiomyopathy; Myocardial Stiffness; Pediatric; Phenotype; Ultrasound
Abstract
Hypertrophic cardiomyopathy (HCM) is a genetic disease in which heart muscle stiffens and become abnormally thick, making it difficult for the heart to pump blood. This disease is a common cause of poor health & even death in children & young adults. We are currently limited to visual inspection done by physicians on ultrasound images of the heart to identify and assess the progression of the disease as there is no other non-invasive technique clinically available to do so. Several known genetic mutations can provide insight about the likelihood of disease in an individual, however the link between mutation & the progression of disease and outcomes is not well known. Lacking a clinical tool to characterize HCM also limits our ability to study the differences in males and females suffering from HCM due to social, hormonal, & genetic reasons. Previous studies have used predominately male populations which may not be suitable for implementing in females. Therefore, we need to improve our ability to identify HCM patients at greater risk. Using a newly developed technology called ultrasound ultrafast imaging, we are now able to non-invasively estimate heart stiffness in HCM patients. The technique has already been used to estimate heart stiffness in healthy & HCM adults. The objective of this research project is to understand the link between heart stiffness, genetic mutation, and clinical events in pediatric and young adult HCM. Having equal number of male & female HCM patients in study will allow us to observe sex-related differences in heart stiffness in HCM patients. In this research study we will recruit infants, youths & young adults with HCM in four hospitals across Ontario. This research project promises to redefine how we diagnose, and access risks in HCM patients.
Competitiondate
202212
Approvedterm2
1 yr 0 mth
Pinamesdelim
Malik, Aimen
Approvedterm
1 an 0 mois
Cihrcontribution2
~ $17,500~ $0~